Physician

Ross Matthew Kennamer-Chapman, MD

According to 2025 Medicare claims, Ross Kennamer-Chapman, MD (NPI: 1245765601) practices ophthalmology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Fayette, GA. This provider's primary affiliated billing organization is GEORGIA RETINA, PC (NPI: 1023027430; TIN: 581519372) and primary practice location at 30269-3577. Kennamer-Chapman is affiliated with the Emory Healthcare Network Advantage (ACO ID: A4771) and VillageMD New Hampshire ACO, LLC (ACO ID: D0106), participating under both the MSSP and REACH models.

Kennamer-Chapman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 895 traditional Medicare patients, billed 22,792 HCPCS/CPT codes, and received $1,631,531 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 708 prescription claims across 219 beneficiaries totaling $28,966 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 34 records totaling $1,003. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,822 to $28,966. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$816K$1.6M2021 Medicare payment: $26,862 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $69,974 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $410,601 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,631,531 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202167163$26,862
202291322$69,974
20234555,998$410,601
202489522,792$1,631,531

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$29K2017 Drug cost: $1,822 (USD; Tot_Drug_Cst)2018 Drug cost: $643 (USD; Tot_Drug_Cst)2019 Drug cost: $20,212 (USD; Tot_Drug_Cst)2020 Drug cost: $1,003 (USD; Tot_Drug_Cst)2021 Drug cost: $28,561 (USD; Tot_Drug_Cst)2022 Drug cost: $24,493 (USD; Tot_Drug_Cst)2023 Drug cost: $21,395 (USD; Tot_Drug_Cst)2024 Drug cost: $28,966 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171242$1,822
20181627$643
201980280$20,212
20201836$1,003
202171202$28,561
202279191$24,493
2023126271$21,395
2024219708$28,966

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye234817$95
92004New patient complete exam of visual system249249$91
92014Established patient complete exam of visual system386462$86
92012Established patient problem focused exam of visual system239376$64
92134Imaging of retina7441,573$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2238,808$10,637
Ketorolac TromethamineKetorolac Tromethamine752,184$2,681
Atropine SulfateAtropine Sulfate702,977$2,580
Brimonidine TartrateBrimonidine Tartrate382,130$1,876
DifluprednateDifluprednate17355$1,285

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$1,003Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ross Matthew Kennamer-Chapman, MD?

Tedicare shows public-source Medicare data for Ross Matthew Kennamer-Chapman, MD (NPI 1245765601), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ross Matthew Kennamer-Chapman, MD have ACO affiliation data?

Ross Matthew Kennamer-Chapman, MD is shown with ACO affiliation data for Emory Healthcare Network Advantage (MSSP, ACO ID A4771) and VillageMD New Hampshire ACO, LLC (REACH, ACO ID D0106).

What billing organization is linked to Ross Matthew Kennamer-Chapman, MD?

Ross Matthew Kennamer-Chapman, MD is linked to GEORGIA RETINA, PC (billing NPI 1023027430) in the available physician profile data.

Does Ross Matthew Kennamer-Chapman, MD have Open Payments data?

Ross Matthew Kennamer-Chapman, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.